Topiramate add-on treatment associated with normalization of prolactin levels in a patient with schizophrenia
Yinglin Huang,1,2 Huan Ma,1 Yuan Wang,2 Miao Peng,2 Gang Zhu1 1Department of Psychiatry, The First Affiliated Hospital of China Medical University, 2Department of Psychiatry, Shengjing Hospital of China Medical University, Shenyang, China Abstract: Topiramate has been used increasingly in the mana...
Guardado en:
Autores principales: | Huang Y, Ma H, Wang Y, Peng M, Zhu G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7fce3565f68f4be1b8643d1dd3232f3d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
por: Okuyama Y, et al.
Publicado: (2016) -
Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia
por: Yang F, et al.
Publicado: (2018) -
Comprehensive review of visual defects reported with topiramate
por: Ford L, et al.
Publicado: (2017) -
Review of topiramate for the treatment of epilepsy in elderly patients
por: BR Sommer, et al.
Publicado: (2010) -
Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
por: Zhi P, et al.
Publicado: (2018)